Christophe Fermé
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial(2010)1,055 cited
- → Phase I study of oxaliplatin in patients with advanced cancer(1990)339 cited
- → ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma(2005)325 cited
- → Extranodal Hodgkin Disease: Spectrum of Disease(2001)272 cited
- → Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study(2003)239 cited
- → Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.(1998)140 cited
- → Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalatedPlus Four Cycles of BEACOPPbaselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial(2016)120 cited
- → Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte(2007)117 cited
- → Sarcoidosis Occurring After Lymphoma(2014)77 cited
- → Survival after Hodgkin lymphoma(2009)76 cited